These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 4150775)

  • 21. Ganglion blockade by muscarine, oxotremorine and AHR-602.
    Jaramillo J; Volle RL
    J Pharmacol Exp Ther; 1967 Oct; 158(1):80-8. PubMed ID: 4383244
    [No Abstract]   [Full Text] [Related]  

  • 22. Cholinoceptive receptors of crayfish stretch receptor neurones.
    McLennan H; York DH
    Comp Biochem Physiol; 1966 Jan; 17(1):327-33. PubMed ID: 4380102
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of cholinergic compounds on spontaneous quantal mediator release at the neuromuscular synapse of the frog].
    Bukharaeva EA; Nikol'skiĭ EE; Giniatullin RA
    Neirofiziologiia; 1986; 18(5):586-93. PubMed ID: 2877404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pharmacology fo gross behavioural effects of cholinomimetic substances injected into the cerebral ventricles of unanaesthetized cats: evidence for central muscarinic mediation.
    Beleslin DB; Grabović L; Radmanović BZ
    Neuropharmacology; 1974 Dec; 13(12):1163-9. PubMed ID: 4457763
    [No Abstract]   [Full Text] [Related]  

  • 25. The action of cholinomimetics on spinal interneurones.
    Curtis DR; Ryall RW; Watkins JC
    Exp Brain Res; 1966; 2(1):97-106. PubMed ID: 5921136
    [No Abstract]   [Full Text] [Related]  

  • 26. An estimate of the muscarinic ganglion blocking potency of atropine.
    Sethi OP; Gulati OD
    Indian J Physiol Pharmacol; 1971 Oct; 15(4):179-82. PubMed ID: 4401548
    [No Abstract]   [Full Text] [Related]  

  • 27. The effects of anticholinesterases on synaptic transmission through nicotinic and muscarinic receptors in rat sympathetic ganglia in vivo.
    Drew GM; Leach GD
    Br J Pharmacol; 1974 Sep; 52(1):51-9. PubMed ID: 4375534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on the neuropharmacology of papaverine. 3. The inhibition of ganglionic transmission.
    Bauer V; Capek R
    Neuropharmacology; 1972 Sep; 11(5):697-701. PubMed ID: 4363891
    [No Abstract]   [Full Text] [Related]  

  • 29. [Mechanism of antiacetylcholine effects of some mononitrous cholinolytics in the neuromuscular synapse].
    Magazanik LG
    Farmakol Toksikol; 1971; 34(3):292-7. PubMed ID: 4398156
    [No Abstract]   [Full Text] [Related]  

  • 30. The interactions of neuromuscular blocking agents in man: the role of hexafluorenium.
    Torda TA; Foldes FF; Bailey RJ; Klonymus DH; Kuwabara S
    Anesthesiology; 1967; 28(6):1010-9. PubMed ID: 4383425
    [No Abstract]   [Full Text] [Related]  

  • 31. The potentiation of neuromuscular blocking agents by quinidine.
    Miller RD; Way WL; Katzung BG
    Anesthesiology; 1967; 28(6):1036-41. PubMed ID: 4383426
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effects of nicotine, DMPP, TMA, amphetamine and KCl on the demarcation potential of the superior cervical ganglion and ganglionic transmission].
    Haefely W; Hürlimann A; Thoenen H
    Helv Physiol Pharmacol Acta; 1967; 25(4):CR418+. PubMed ID: 4385361
    [No Abstract]   [Full Text] [Related]  

  • 33. Late contraction of nictitating membrane of the dog.
    Chen SS
    Am J Physiol; 1969 Oct; 217(4):1205-10. PubMed ID: 4390468
    [No Abstract]   [Full Text] [Related]  

  • 34. [Antinocifensive effect of nicotine including methodical description of an automatic focal ray device].
    Andreas K; Wagner U; Eichmann H; Legler R
    Acta Biol Med Ger; 1972; 29(3):423-9. PubMed ID: 4649055
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of lidocaine on ganglionic transmission].
    Ozawa M; Otsuki K; Aihara H
    Nihon Yakurigaku Zasshi; 1967 Sep; 63(5):402-8. PubMed ID: 4296569
    [No Abstract]   [Full Text] [Related]  

  • 36. Letter: Do adrenergic fibres have muscarinic inhibitory receptors?
    Burn JH
    J Pharm Pharmacol; 1974 Mar; 26(3):212-5. PubMed ID: 4151085
    [No Abstract]   [Full Text] [Related]  

  • 37. Antagonism of deslanoside-induced cardiotoxicity by combined nicotinic and muscarinic blockade of autonomic ganglia.
    Gillis RA; Jolson H; Thibodeaux H; Levitt B
    J Pharmacol Exp Ther; 1975 Oct; 195(1):126-32. PubMed ID: 241837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pharmacology of the nicotinic antagonist, chlorisondamine, investigated in rat brain and autonomic ganglion.
    Clarke PB; Chaudieu I; el-Bizri H; Boksa P; Quik M; Esplin BA; Capek R
    Br J Pharmacol; 1994 Feb; 111(2):397-405. PubMed ID: 7911713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential blockage and potentiation of transmission in a sympathetic ganglion.
    Kayaalp SO; McIsaac RJ
    J Pharmacol Exp Ther; 1970 May; 173(1):193-204. PubMed ID: 4315155
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of lithium ions on electrical activity in sympathetic ganglia of the bullfrog.
    Koketsu K; Yamamoto K
    Br J Pharmacol; 1974 Jan; 50(1):69-77. PubMed ID: 4150891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.